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Abstract
Background: Tauopathy in the central nervous system (CNS) is a histopathological hallmark of frontotemporal
dementia (FTD) and Alzheimer’s disease (AD). Although AD is accompanied by various ocular changes, the effects
of tauopathy on the integrity of the cornea, which is densely innervated by the peripheral nervous system and is
populated by resident dendritic cells, is still unknown. The aim of this study was to investigate if neuroimmune
interactions in the cornea are affected by CNS tauopathy.
Methods: Corneas from wild type (WT) and transgenic rTg4510 mice that express the P301L tau mutation were
examined at 2, 6, 8, and 11 months. Clinical assessment of the anterior segment of the eye was performed using
spectral domain optical coherence tomography. The density of the corneal epithelial sensory nerves and the
number and field area of resident epithelial dendritic cells were assessed using immunofluorescence. The
immunological activation state of corneal and splenic dendritic cells was examined using flow cytometry and
compared between the two genotypes at 9 months of age.
Results: Compared to age-matched WT mice, rTg4510 mice had a significantly lower density of corneal nerve
axons at both 8 and 11 months of age. Corneal nerves in rTg4510 mice also displayed a higher percentage of
beaded nerve axons and a lower density of epithelial dendritic cells compared to WT mice. From 6months of age,
the size of the corneal dendritic cells was significantly smaller in rTg4510 compared to WT mice. Phenotypic
characterization by flow cytometry demonstrated an activated state of dendritic cells (CD86+ and CD45+
CD11b+CD11c+) in the corneas of rTg4510 compared to WT mice, with no distinct changes in the spleen
monocytes/dendritic cells. At 2 months of age, there were no significant differences in the neural or immune
structures between the two genotypes.
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Conclusions: Corneal sensory nerves and epithelial dendritic cells were altered in the rTg4510 mouse model of
tauopathy, with temporal changes observed with aging. The activation of corneal dendritic cells prior to the
gradual loss of neighboring sensory nerves suggests an early involvement of corneal immune cells in tau-associated
pathology originating in the CNS.
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Introduction
Alzheimer’s disease (AD) and tau-related variants of frontotem-
poral dementia (FTD) are neurodegenerative diseases character-
ized by the pathological accumulation of tau in the central
nervous system (CNS). The accumulation of hyperphosphory-
lated tau, concomitant with the progressive formation of neuro-
fibrillary tangles (NFTs), further drives impairment of cellular
trafficking [1], synaptic dysfunction [2, 3], cognitive deficits [4],
and neuronal loss [5, 6]. The effect of CNS degeneration on
ocular health [7], such as retinal nerve fiber thinning and retinal
neuronal loss, has been described both in patients [8–10] and
mouse models of tauopathy [11–13]. As one of the most highly
innervated tissues of the body, the cornea has recently been
used in clinical studies to non-invasively examine peripheral
nervous system pathology secondary to CNS neurodegenera-
tion in vivo [14–20]. However, there is a paucity of preclinical
studies aiding the elucidation of causative factors behind corneal
changes in neurodegenerative disorders.
The cornea is supplied by sensory nerve axons that form
part of the peripheral nervous system (PNS) [21, 22]. A
rich supply of sensory nerves originates from the ophthal-
mic branch of the trigeminal nerve and ramifies to form a
plexus in the sub-basal region of the corneal epithelium.
Nerve axons branching from the sub-basal nerve plexus
(SBNP) extend processes, which ramify and terminate
through the entirety of the epithelium where they form
the superficial nerve terminals (SNT) [23]. Corneal nerves
provide trophic support to maintain both the homeostasis
of the corneal epithelium and functional integrity of the
ocular surface [24]. Among the resident immune cells,
epithelial dendritic cells (DCs) predominantly reside in the
basal epithelium of the human [25, 26] and mouse cornea
[27, 28], where they not only serve as immune sentinels
[29, 30] but also act as a bridge between the innate and
adaptive immune systems [31]. Most DCs in the corneal
epithelium are located peripherally, with a decline in num-
bers centrally [26]. Growing evidence shows the involve-
ment of resident corneal DCs in maintaining the
homeostasis of corneal nerves [32], suggesting a direct
interaction between the immune system and peripheral
nerves at the ocular surface.
Corneal epithelial DCs and nerves can be visualized
and quantified by corneal confocal microscopy, which is
a non-invasive ophthalmic imaging tool [33, 34]. Emer-
ging evidence indicates a decline in the corneal nerve
fiber density in patients with Parkinson’s disease (PD)
[35, 36], small fiber neuropathy [17] and Multiple Scler-
osis (MS) [14, 15]. Recently, reduced corneal sensitivity
and altered tear production were reported in individuals
with Alzheimer’s disease (AD) [37]. Corneal nerve fiber
loss has been shown in patients with mild cognitive im-
pairment (MCI) and dementia, with a strong correlation
evident between corneal nerve fiber loss and decreasing
cognitive function [16]. However, the precise changes
that occur to the neuroimmune interactions between
corneal nerves and resident DCs are still unknown in
the context of CNS degenerative diseases.
In order to understand the peripheral manifestations of
CNS degeneration at the ocular surface, we characterized the
temporal effect of CNS tauopathy on the integrity of corneal
nerves and resident DCs using the rTg(tauP301L)4510 mouse
model of tauopathy [4]. The rTg4510 model overexpresses
doxycycline-repressible human mutant tau with the MAPT
P301L mutation, which is associated with genetic forms of
FTD-tau, under the control of the Ca2+-calmodulin-
dependent protein kinase II (CaMKII) promoter [4]. It is im-
portant to note that these random insertions led to disruptions
in a number of endogenous genes [38], which exacerbate
phenotypic changes in rTg4510 [39]. Nonetheless, among the
models of tauopathy, the hTau in these mice promotes pro-
gressive age-related NFTs, neuronal loss concomitant with
the tau accumulation in the forebrain and hippocampus,
followed by the substantial neurodegeneration [4, 6, 40–43],
reminiscent of tauopathy in patients with FTD-tau [44]. In this
animal model, we report that both peripheral nerves in the
cornea and epithelial DCs were altered in mice with the age-
related accumulation of pathological tau. Corneal DC morph-
ology was affected prior to corneal nerve degeneration, sug-
gesting that DCs may be involved in the peripheral nerve
abnormalities in the presence of CNS tauopathy. This study
implicates the potential utility of using corneal neuroimmune
phenotypes as landmarks to identify peripheral neuropathol-
ogy secondary to the CNS degeneration.
Methods
Animals
Male and female wild type (WT) and tau transgenic lit-
termates (rTg4510) were bred and housed under specific
pathogen-free conditions at the Florey Institute of
Neuroscience and Mental Health. Age-matched WT and
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rTg(tauP301)4510 mice were examined at 2, 6, 8, and
11months of age (n = 6–8 per group per age). All animal
procedures were approved by the Animal Ethics Commit-
tee at the Florey Institute of Neuroscience and Mental
Health and complied with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
Spectral domain optical coherence tomography
The anterior segment was examined using SD-OCT to en-
sure there were no clinical signs of inflammation (i.e., in-
flammatory cells, corneal edema, corneal opacity, or
epithelial erosions) or other structural abnormalities in
the anterior segment of the eye. Euthanized mice were
placed on the animal imaging platform and rodent align-
ment stage (AIM-RAS) attached to an SD-OCT imaging
device (Bioptigen Envisu R22200 VHR; Bioptigen, Inc.,
Durham, NC, USA). Volumetric 3 mm × 3mm rectangu-
lar scans of the anterior segment were captured using an
OCT device with an 18-mm telecentric lens. Central cor-
neal thickness was determined by measuring the distance
from the tear film to the endothelium using the ImageJ
software (http://imagej.nih.gov/ij/; National Institutes of
Health, Bethesda, MD, USA), as previously described [45].
Wholemount immunofluorescence and confocal
microscopy
Corneas from age-matched WT and rTg4510 mice were
collected at 2, 6, 8, and 11months of age and fixed in
100% methanol for 1 h at −20 °C. After three washes in
PBS, corneas were permeabilized in 20mM EDTA for 40
min at 37 °C and then blocked in PBS containing 3% BSA-
PBS and 0.3% Triton X-100 for 1 h at room temperature.
Tissues were stained using a combination of primary anti-
bodies to identify nerves (rabbit α-β-tubulin III, 1:500,
Sigma T2200, St Louis, MO, USA) and DCs (rat α-CD45,
1:500, BD Biosciences, Franklin Lakes, NJ, USA). The pri-
mary antibody incubation was kept at 4 °C overnight and
the corneas were washed and incubated with correspond-
ing secondary antibodies goat α-rabbit 647 and goat α-rat
Cy3 (1:1000, Invitrogen, Carlsbad, CA, USA) for 2 h at
room temperature. Corneas were examined with a fluores-
cence microscope (Olympus BX511, Zeiss) to measure
dendritic cell density and morphology, and with a confocal
microscope (Leica TCS SP8; Leica, Germany) to visualize
corneal nerves.
Confocal Z-projections were generated for the SBNP
and SNT. Area thresholds, which measure the percentage
field area occupied by corneal nerves, were quantified sep-
arately for the SBNP and SNT in the central and periph-
eral corneal regions, as previously described [46, 47]. All
image analyses were carried out in a masked fashion, with
the genotypes unmasked after the data acquisition for
each age cohort. Corneal nerve beading was measured
using the Z-stacked images of the SBNP. A series of binary
conversions were performed using the default method of
thresholding in Image J ("Auto-Threshold"). The image
was further processed to create the binary images (total
nerve projections, continuous and beaded) for each con-
focal image using 'Subtracting Background' and "Shape
Filter". The percentage of 'nerve beading' was calculated
(raw integrated density of "nerve beads"/full nerve length
× 100) for the central and peripheral cornea. DC morpho-
metric analyses were carried out on images of CD45+ DCs
using × 10 objective (600 μm × 900 μm). One field from
the central cornea and two fields from the peripheral cor-
nea were used for image analysis (DC cell density and
morphometric parameters). DC morphometric analyses
included DC field area, cell area, total dendrite length
(TDL), and number of dendrites per cell using the estab-
lished protocol in humans [48, 49] and mice [50, 51]. In
brief, each cell of interest, isolated by a ROI, was proc-
essed through a local threshold and skeletonized, for the
cell area and TDL analysis, respectively (Fig. 3). Each par-
ameter had a total of 20–30 cells included for the periph-
eral cornea and 1–3 cells for the central cornea. Each
datapoint on the graph represents the mean for an indi-
vidual mouse.
Quantitative real-time polymerase chain reaction (qPCR)
Corneas were stabilized in RNAlater solution overnight at
4 °C before being dissected and processed for RNA extrac-
tion (n = 11 per genotype) using PureLink RNA Mini Kit
(Invitrogen, Life Technologies) according to manufac-
turer’s instructions. Each sample containing two corneas
per mouse was homogenized in lysis buffer containing β-
mercaptoethanol using QIAGEN TissueLyser II. PureLink
DNase was added to each spin column containing the
resulting RNA to prevent contamination. RNA concentra-
tion and quality were assessed by ND-2000 spectropho-
tometer (Nanodrop technologies, USA) for each sample
and stored at −80 °C. cDNA was prepared from 500 ng of
each RNA sample using Tetro cDNA Synthesis Kit (Bio-
line, London, UK) according to manufacturer’s protocol.
Gene expression changes were measured via qPCR
using Taqman assays for Gapdh (Mm99999915_g1,
Entrez Gene ID: 131530) and CaMKIIa (Mm00437967_
m1 Entrez Gene ID: 304088) and Taqman Gene Expres-
sion Master Mix (Thermo Fisher Scientific). Each qPCR
(duplicates) was run using the QuantStudio 12 K Flex soft-
ware on the Vii7A Real-Time PCR system at the Mel-
bourne Brain Centre (Applied Biosystems, USA). Analysis
was performed using the 2 − ΔΔCt method, which was
normalized to the expression of the housekeeping gene.
Flow cytometry of corneas and spleens
Corneas from 9-month-old WT and rTg4510 mice (n =
6 per genotype) were excised and pooled (4 corneas, 2
animals per tube, n = 3). Excised corneas were digested
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in sodium medium containing 2 mg/mL collagenase D
(Roche, Indianapolis, IN) and 0.5 mg/mL DNase I
(Roche, Indianapolis, IN) for 30 min at 37 °C. Repetitive
trituration was performed after the digestion using a
sterilized glass Pasteur pipette. Single cell suspensions
were filtered through a 70 μm mesh (BD Biosciences)
and centrifuged at 4 °C, 600g for 5 min. The pellet was
resuspended in sodium medium [52] (145 mM NaCl, 5
mM KCl, 0.1 mM Ca2+, 10 mM HEPES, 0.1% BSA, 5
mM d-glucose pH 7.5) containing CD16/32 receptor
block to avoid non-specific staining. Flow cytometry
antibodies, including CD11b-PE, CD45-FITC, and
CD11c-PeCy7 (1:400, BD Biosciences, Franklin Lakes,
NJ, USA) along with isotype control antibodies, were
used to isolate DCs from the mouse corneas, while
CD86, MHC-class II, and CD80 all conjugated to allo-
phycocyanin fluorophore (APC) were used to separately
visualize the activation status of the DCs. The staining
process for the aliquoted single cell suspension was per-
formed on an orbital shaker at 4 °C for 30 min. Un-
stained controls omitting the above antibodies were also
included to confirm the positive and negative cell popu-
lation. Following the staining, the cells were washed
twice in Dulbecco’s phosphate-buffered saline (DPBS),
centrifuged at 4 °C, 600g for 5 min and resuspended in
sodium medium. The single-cell suspension was assessed
on CytoFlex S Flow Cytometer (Beckman Coulter).
UltraComp eBeads Compensation Beads (Invitrogen, 01-
2222-41) and single-stained corneal samples were used
to establish and validate compensation gates for the
above antibody combinations. The FlowJo software (v10)
was used to analyze the data in both genotypes.
Statistical analyses
All statistical analyses were performed using Prism 7
(GraphPad Software, CA, USA). Statistical significance
was assessed using a one-way ANOVA or two-way
ANOVA (as appropriate). Unpaired Student's t-tests were
performed to compare WT and rTg4510 mice for corneal
thickness, while a two-way ANOVA was performed to
compare the corneal cellular characteristics (nerve and
DC parameters in the different age groups). Tukey’s post
hoc tests were applied where multiple statistical compari-
sons were performed. Unpaired Student's t tests were per-
formed to assess the comparisons at each age group. An
alpha of 0.05 was used to define statistical significance.
Results
Structural integrity in the anterior segment of rTg4510
mice
The anterior segment of WT and rTg4510 mice aged 11
months were examined using SD-OCT to determine if
CNS tauopathy was associated with any overt structural
or cellular corneal pathology (Fig. 1). There were no
structural abnormalities observed in the anterior segment
(i.e., cellular infiltrates, epithelial disruption, stromal
edema) of rTg4510 compared to WT mice (Fig. 1a–f).
There were also no significant differences in central cor-
neal epithelial thickness (Fig. 1g, P > 0.05) or stromal
thickness in rTg4510 mice compared to WT (Fig. 1h, P >
0.05).
Disrupted corneal nerve architecture in rTg4510 mice
Corneal sensory nerve density and morphology were
assessed in WT and rTg4510 mice aged 2, 6, 8, and 11
months using β-tubulin wholemount immunostaining.
In the superficial epithelial layer, there was a higher
density of SNTs (Fig. 2a, b) in the central corneas of
WT mice compared to rTg4510 mice (Fig. 2c, d) at 11
months of age. Area threshold analysis confirmed that
the density of the SNTs, in the central cornea, was sig-
nificantly lower in rTg4510 mice compared to WT, at
11 months (Fig. 2e, P < 0.05), but not at 2, 6, or 8
months of age (Fig. 2e, P > 0.05 at each time point). In
the peripheral region, there was no significant difference
in the density of the SNTs between rTg4510 and WT
mice across the age groups (Fig. 2f, P > 0.05).
In the basal epithelial layer, the density of β-tubulin+
nerve axons forming the SBNP was lower and appeared to
demonstrate a highly beaded morphology in both the cen-
tral and peripheral cornea of rTg4510 compared to WT
mice at 11months of age (Fig. 2g–n). The density of β-
tubulin+ nerve axons was lower in both central corneal
(11 months) and peripheral corneal regions (8 and 11
months) of rTg4510 compared to WT mice (Fig. 2o, p, P
< 0.05 for both comparisons). Additionally, the nerve
axons in both corneal regions displayed a significantly
higher proportion of nerve beading in rTg4510 compared
to WT mice at 11months of age (Fig. 2 q, r, P < 0.05).
Altered morphology and distribution of epithelial
dendritic cells in rTg4510 mice
Corneal epithelial DCs were visualized by CD45 immu-
nohistochemistry. CD45+ cells were visible in the central
and peripheral corneal epithelium of WT (Fig. 3a–c) and
rTg4510 mice (Fig. 3d–f). There was no significant dif-
ference in DC density between WT and rTg4510 mice
in the central cornea at 2, 6, 8, and 11 months of age
(Fig. 3g, P > 0.05 for each comparison). In the peripheral
corneal epithelium, DC density was significantly lower in
rTg4510 mice aged 8 and 11months compared to WT
mice (Fig. 3h, P < 0.05 at both time points). DC morpho-
metric parameters (DC field area, cell area, TDL, and
number of dendrites per cell) used clinically as an indi-
cator of DC “maturity” in the corneal epithelium [48] re-
vealed no significant intergroup differences in the
central cornea (Fig. 3i–l), except for a higher cell area in
the 8-month-old WT mouse corneas compared to
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rTg4510 mice (Fig. 3j, P < 0.05). In the peripheral cor-
nea, DC field area was significantly smaller in rTg4510
mice at 6 months of age, and this small field area per-
sisted at 8 and 11months (Fig. 3m, P < 0.05). Cell area
did not differ between WT and rTg4510 for any age
group (Fig. 3n, P > 0.05). TDL and number of dendrites
per cell were substantially lower in the 11-month-old
rTg4510 mouse corneas compared to the aged-matched
WT (Fig. 3o, p, P < 0.05).
Phenotypic analysis of corneal DCs in the presence of
tauopathy
Previous flow cytometry studies of the mouse cornea
have demonstrated that resident epithelial DCs are
CD11c+CD11b−, whereas the stromal DCs are
CD11c+CD11b+ [53, 54]. Using this paradigm to quanti-
tatively assess corneal DC phenotype, we next investi-
gated the effect of tauopathy on the immunophenotype
of corneal DC populations. Here, we adopted a similar
gating strategy to compare the activation status of
CD11c+CD11b− “epithelial” DCs and CD11c+CD11b+
“stromal” DCs in WT and rTg4510 mice at 9 months of
age (Fig. 4a, b). While the total frequency of each popu-
lation was not markedly different between WT and
rTg4510 mice (Fig. 4b), the proportion of CD86+ cells
was substantially higher in CD11c+CD11b− epithelial DC
and CD11c+CD11b+ stromal DC populations of rTg4510
mice (stromal, 48.8%; epithelial, 4.74%) compared to WT
mice (stromal, 30.2%; epithelial, 1.87%) (Fig. 4c). The
percentage of CD11c+CD11b− CD80+ “epithelial” DCs
was also higher in the rTg4510 mouse corneas (epithe-
lial, 6.94%) compared to WT mice (epithelial, 2.08%)
(Fig. 4d). Flow cytometric plots of absolute numbers
show that the epithelial DC had a higher number of
CD86+ and CD80+ population in rTg4510 mouse cor-
neas compared to WT (Fig. 4e). The stromal DCs also
demonstrated a higher number of CD86+ and CD80+
cells in the corneas of rTg4510 mice compared to WT
Fig. 1 Spectral domain optical coherence tomography (SD-OCT) images of the anterior segment from wild type mice and rTg4510 mice aged 11
months. a En face view of the WT mouse eye (3 mm × 3mm rectangular scan) and b corresponding SD-OCT scan of the anterior segment. Red
arrowed line represents the en face location of the scan. c, f Structure of the corneal epithelium and stroma, as shown using SD-OCT. No visible
differences in the corneal structure or anterior segment were observed between WT (a-c) and rTg4510 mice (d-f). g, h There were no
quantitative differences in corneal epithelial (g) or stromal thickness (h) between WT and rTg4510 mice. Data are shown as mean ± SEM where
NS represents a comparison that is not statistically significant (n = 8 per group) as assessed using unpaired Student's t-test. Scale bars represent
200 μm in Fig. 1 a and d, and 100 μm (vertical axis), and 200 μm (horizontal axis) in Fig. 1 b and e
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(Fig. 4e). These data suggest an activated phenotype of
corneal DC subsets in this mouse model of tauopathy.
Phenotypes of splenic immune cells in rTg4510 mice
To interrogate whether the presence of systemic inflam-
mation accompanied the altered corneal DC phenotype,
we analyzed the frequency and activation profile of
CD45+ CD11b+ CD11c+ and CD45+ CD11b− CD11c+
populations in spleens of rTg4510 and WT mice at 9
months of age (Fig. 5). In the rTg4510 mouse cornea,
CD45+ leukocyte frequency of live splenocytes was simi-
lar to age-matched WT mice (Fig. 5a, b). In the
CD45+CD11b+ and CD45+CD11c+ populations, the per-
centages of CD86+ and CD80+ populations were similar
between WT and rTg4510 mice (Fig. 5c). The compara-
tive plots of absolute cell numbers demonstrate that
there was a rise in the abundance of CD86+ and CD80+
cells in the CD11b+ splenocyte populations of the
Fig. 2 Regional distribution, density and morphology of corneal sensory nerves in WT and rTg4510 mice at 2, 6, 8, and 11months. a–d
Representative images of the superficial nerve terminals (SNT) in the corneas of WT and rTg4510 mice at 11 months. β-tubulin III+ SNTs can be
abundantly seen in the central and peripheral cornea of WT mice (a, b), while rTg4510 mice had a relatively sparse distribution in the central
cornea but were spared in the peripheral cornea (c, d). e, f Percentage area demonstrates a significantly lower density of SNTs in the central
cornea of rTg4510 compared to WT mice at 11 months (P < 0.05), while the peripheral cornea showed no significant intergroup difference across
the age groups (P > 0.05). g–n Representative images of the sub-basal nerve plexus (SBNP) in corneas of WT and rTg4510 mice showing a lower
abundance of SBNPs that appeared in a beaded morphology in the central and peripheral areas of rTg4510 mouse corneas (m, n; yellow
arrowheads). o, p The density of SBNPs was significantly lower in the central cornea of rTg4510 compared to WT mice at 11 months (P < 0.05),
while the lower SBNP density occurred in the peripheral cornea from 8months and persisted to 11months (P < 0.05). q, r The extent of nerve
beading that characterizes the morphology of SBNPs was analyzed; the percentage of beaded nerves was remarkably higher in both central and
peripheral regions of rTg4510 mouse corneas at 11 months (P < 0.05) but not in the younger age cohorts (P > 0.05). Data are shown as mean ±
SEM, where * indicates P ≤ 0.05 (n = 6 per group) as demonstrated using two-way ANOVA and Tukey’s multiple comparisons. Scale bars
represent 100 μm for all images except for f–n where the scale bars are 10 μm
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Fig. 3 Dendritic cells in the central and peripheral corneal epithelium of WT and rTg4510 mice at 2, 6, 8, and 11months. a–f Representative
images of CD45+ DCs show higher abundance in the peripheral versus central cornea for both genotypes, with few DCs across the peripheral
area in rTg4510 mice at 11 months (d–f). c, f In rTg4510 mice, CD45+ DCs had an altered, amoeboid morphology compared to WT at 11 months.
g The central cornea showed no significant inter-group differences at any age (P > 0.05). h Substantial differences were observed in the
peripheral cornea, whereby there was a significantly lower DC density in rTg4510 mice compared to WT mice, at both 8 and 11 months (P <
0.05). i–p DCs were analyzed for field area, cell area, total dendrite length (TDL), and number of dendrites per cell. There was no genotype
difference in the central cornea except for a larger cell area in the 8-month-old WT mice compared to rTg4510 mice (j, P < 0.05). m–p In the
peripheral cornea, DC field areas were significantly smaller in rTg4510 mice compared to WT, at 6, 8, and 11 months of age (m, P < 0.05). Cell area
analysis shows no significant genotype difference (n). TDL and number of dendrites per cell were less in the 11-month-old rTg4510 mice
compared to WT (o, p; P < 0.05). q Morphometric methods for field area, cell area, TDL, and number of dendrites per cell. Scale bars represent
100 μm. Date are shown as mean ± SEM, where * indicates P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 as determined using the two-way ANOVA and
Tukey’s multiple comparisons
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rTg4510 mice compared to WT mice (Fig. 5d). The
splenic CD11c+ population, on the other hand, showed
no notable differences in the size of CD86+ and CD80+
populations between WT and rTg4510 mice (Fig. 5d).
Quantification of flow cytometry data
In corneas, the proportion of CD45+ leukocytes was signifi-
cantly lower in rTg4510 cohorts at 9months of age compared
to WT mice (Fig. 6a, P < 0.05). Representative dot plots dem-
onstrate the shift towards an elevated population of
CD11c+CD80+ and CD11c+ CD86+ in rTg4510 mice (Fig. 6b).
The positive populations of CD80 and CD86 were then con-
firmed by the unstained control and isotype control antibodies,
which depict the negative populations in both cornea and
spleen tissues (Fig. 6c and Supplementary Fig. 2S). Among
CD11c+CD11b+ DCs, rTg4510 mouse corneas had a signifi-
cantly higher proportion of CD80+ and CD86+ “activated”
populations compared to WT mice (Fig. 6d, e, P < 0.05). This
shift towards the “activated” DC phenotypes in rTg4510 co-
hort was also significant in the “stromal” CD11c+CD11b+ DC
Fig. 4 Representative flow cytometric plots showing different populations of dendric cells in the cornea of WT and rTg4510 mice at 9 months of
age. a, b Gating strategies for enumeration of CD45+CD11c+ CD11b+ stromal DCs and CD45+CD11c+ CD11b− epithelial DCs in WT and rTg4510
mice. c Frequencies of CD86+ stromal and epithelial DCs in two genotypes. rTg4510 mice had a higher proportion of CD86+ stromal DCs (48.8%)
compared to WT (30.3%). Proportion of CD86+ epithelial DCs were also substantially higher in rTg4510 (4.74%) compared to WT (1.87%). d
Proportion of CD80+ stromal DCs was 82.5% in WT and 88.% in rTg4510. Epithelial DCs, however, comprise a higher proportion of the CD80+
population in rTg4510 (6.94%) than WT (2.08%). e The corneas from rTg4510 mice had a higher percentage of CD86+ epithelial DCs and stromal
DCs compared to WT as well as higher percentage of CD80+ epithelial DCs and stromal DCs at 9 months of age
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subsets (Fig. 6f, g, P < 0.05). Among CD11c+ and CD11b+ im-
mune cell subsets existing in the spleen, the proportion
of CD45 leukocytes (Fig. 6h, P > 0.05), CD80+, and
CD86+ DCs was not statistically different between
WT and rTg4510 cohorts (Fig. 6i–l, P > 0.05).
Gene expression of CaMKIIa in the mouse cornea
In this mouse model of tauopathy, tau transgene ex-
pression is dependent on the CaMKIIa promoter
which drives transgene expression in the forebrain.
We investigated whether CaMKIIa is expressed locally
Fig. 5 Spleen flow cytometric plots showing the phenotypes of CD45+ cell populations in WT and rTg4510 at 9 months. a Gating scheme for
splenocytes isolation showing DAPI-population was used for the downstream analysis. b Total CD45+ cells were not different between WT
(99.9%) and rTg4510 mice (99.8%). c The proportion of CD86+ and CD80+ population was low in WT and displayed no substantial changes in
rTg4510 mice. d The absolute number of CD86+ and CD80+ showed no difference in the CD11c+ splenocytes between the two genotypes, but a
higher number of CD86+ and CD80+ cells in the CD11b+ splenic immune subset of rTg4510 mice compared to WT mice
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within the corneas of WT and rTg4510 (Supplemen-
tary Fig. 1S). There was no detectable expression of
CaMKIIa in the corneas, as well as no significant dif-
ference in its expression between WT and rTg4510
cohorts at 4 months of age (Supplementary Fig. 1S, P
> 0.05). This observation confirms that the corneal
neuropathology was not driven by local tau transgene
expression.
Discussion
In this study, we characterized the temporal effects of
CNS pathological tau accumulation on the corneal
Fig. 6 Quantification of cornea and spleen flow cytometry data in WT and rTg4510 cohorts. a There was a significantly lower frequency of CD45+
leukocytes in rTg4510 corneas compared to WT mice. b Representative dot plots demonstrate the shift in the “activated” DC phenotypes (CD80+
and CD86+) that are more prominent in rTg4510 cohorts. c Unstained samples of cornea and spleen tissues show the negative populations thus
serving as a guide for identifying the positive population of CD80/CD86. d, e In the CD11c+CD11b+ corneal DC subset, the proportion of CD80+
and CD86+ DCs was reduced in WT mice compared to rTg4510 mice (P < 0.05). f, g Similar declines in the CD80+ and CD86+ DC populations
were observed in CD11c+CD11b− subset (P < 0.05). h–l Comparing WT and rTg4510 spleen tissues, no significant change in CD45, CD80, and
CD86 populations was found in splenic CD11c+ or CD11b+ immune cell subsets (P > 0.05). Data are shown as mean ± SEM, where * indicates P
≤ 0.05 (n = 3 per group for corneas and n = 4 per group for spleens) as determined using the unpaired Student's t-test
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neuroimmune phenotype in mice. Our data demonstrate,
for the first time, that corneal nerves and DCs are altered
in a mouse model of tauopathy, indicating a peripheral
manifestation of CNS tauopathy and/or neurodegenera-
tion. Furthermore, in rTg4510 mice, corneal DCs dis-
played an altered immunophenotype (lower field area,
total dendrite length, and number of dendrites per cell), a
lower cell density, and an activated status. The differences
in DC morphology were most apparent in the peripheral
cornea, with the lower field area apparent by 6months in
rTg4510 mice, which occurred prior to the nerve differ-
ences. Lastly, there was a minimal effect of CNS tauopathy
on the immunophenotype of analogous cell populations in
the spleen. These unexpected findings highlight the possi-
bility that examining corneal neuroimmune features could
provide a novel strategy to detect the peripheral manifes-
tations of CNS tauopathy, and further reflect the severity
of the tau-driven neurodegenerative processes.
The axonal atrophy of neurons is a pathological hallmark
of neurodegenerative conditions, such as AD [55, 56] and
other tauopathies [57]. Tau that aggregates in neurons can
propagate via cell-to-cell spreading, leading to the impair-
ment of neuronal networks [58]. Our data, showing the
temporal pattern of corneal nerve axonopathy in the pres-
ence of CNS tauopathy, suggest a PNS manifestation in
rTg4510 mice that expresses forebrain-specific hyperpho-
sphorylated tau. The occurrence of the corneal neuropath-
ology coincided with the reported increasing levels of tau
burden in the cortex and hippocampus at 8months of age,
along with severe brain atrophy and cognitive impairment
at 12months [6, 42]. Furthermore, our CaMKIIa gene ex-
pression data confirm that these corneal neuropathological
phenotypes were not driven by local tau transgene expres-
sion, which is under the control of the CaMKIIa promoter,
suggesting a likelihood of a secondary manifestation of
CNS pathology. This concept of peripheral manifestation of
CNS pathology is reported in the PS19Tg mouse model of
tauopathy where mice develop motor dysfunction and sci-
atic nerve pathology, accompanied by a high abundance of
mutated tau proteins in the sciatic nerves [59].
The mechanism underlying the impaired corneal nerves
in rTg4510 mice is not entirely understood. In cross-
sectional studies of individuals with PD, evidence of a dec-
rement in the anisotropic component of white matter fi-
bers in the early trigeminal nerve was detected by
magnetic resonance imaging [60]. In addition, lower cor-
neal nerve density and nerve length has been reported in
individuals with PD [20, 35, 36]. Tau propagation is re-
ported to depend on neural connectivity. For example, an
abundance of hyperphosphorylated tau is reported in the
brainstem and spinal cord [61]. While evidence for the
propagation of misfolded tau proteins is emerging [61,
62], future studies are necessary to confirm the presence
of abnormal tau in the trigeminal ganglion where the
neuronal cell bodies of the corneal nerves are located and
merge into a single, large sensory root entering the
brainstem.
The alterations to corneal nerve architecture already
identified clinically in PD [35, 36], MS [14, 15], and AD
[16, 37], led us to postulate that, in addition to corneal
neuropathology, corneal DCs might also be affected in
the mouse model of tauopathy due to the known intim-
ate neuroimmune crosstalk in the corneal epithelium.
DCs secrete neurotrophins, such as ciliary neurotrophic
factor, that regulate corneal sensory nerves during
homeostasis and following nerve injury [47]. Pharmaco-
logical depletion of DCs in the mouse cornea has been
shown to correlate with lower corneal nerve densities
under homeostatic conditions [32] and following injury
[47]. We found that the lower density of corneal nerve
axons in the peripheral cornea paralleled a lower DC
density in the mouse model of tauopathy. The gradual
age-related increase in SBNP measurements in the aged
WT mice may be explained by a true physiological in-
crease in SBNP, as has been reported in rats [63]. How-
ever, other studies in mice report a decline in nerve
density with aging [50, 64]. Furthermore, corneal nerve
density differs according to strain [65]. In our study, all
mice were on an Agouti background; thus, it is possible
that this strain may have different nerve densities com-
pared to the C57BL/6 strain. It is also worthwhile to
note that a range of approaches have been used to meas-
ure corneal nerves, including thresholding [46, 47, 66],
nerve tracing [46, 50], Scholl analysis [67], or a combin-
ation of manual tracing and thresholding [65]. This is an
ongoing challenge in the literature, and thus while we
acknowledge that thresholding has its limitations, we
have controlled for this as best as possible by performing
all immunostaining runs for age-matched cohorts in
parallel.
The presence of corneal nerve beading in the rTg4510
aged cohort may indicate a nerve repair process, as has
been described in individuals with dry eye disease [68],
ultraviolet keratitis [69], and diabetes [70]. Nerve bead-
ing may indicate an abnormal accumulation of organ-
elles that results in disrupted axonal transport [71].
Further studies are warranted to investigate the under-
lying mechanisms that drive corneal nerve axonopathy
in the mouse model of tauopathy. Furthermore, mea-
surements of physiological parameters, such as tear pro-
duction, tear osmolarity, and corneal sensitivity, are of
interest to determine if the described corneal nerve
changes relate to altered ocular surface function.
In addition to direct tau-induced axonal impairment,
the diminishing presence of corneal DCs may also im-
pair the trophic support provided to the corneal nerves
[57] in the rTg4510 mice. However, other studies have
reported that higher corneal DC densities are associated
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with a lower nerve density in individuals with MS [14]
and diabetes [72]. This discrepancy may be explained by
the chronic systemic inflammation that occurs in these
disease conditions. This systemic inflammation was not
evident in our mouse model of tauopathy, as shown by
the minimal effect of tauopathy on the population of ac-
tivated splenic immune cell subsets.
Our study provides novel evidence of an altered corneal
DC morphology and activated phenotype in the mouse
model of pathological tau accumulation. Corneal DCs
adopt different patterns in their distribution, density, and
morphology under local and systemic inflammatory con-
ditions in mice [51, 73]. Here, we report that the abnor-
malities in DC morphology reflect an activated phenotype
in the transgenic mouse model of FTD. To interrogate the
activation state of corneal DCs with a smaller field area,
we focused on epithelial and stromal DC subsets [53] due
to their central role in corneal immunity [74], their clinical
relevance [48], and their capacity to undergo maturation
through enhanced expression of activation markers, such
as CD86 and CD80 in inflamed corneas [27, 73]. We
found that the proportion of both CD86+ and CD80+ epi-
thelial DCs were higher in tau transgenic mice, suggesting
that morphological and density differences in the epithelial
DCs were associated with upregulated cell surface expres-
sion of activation markers. In the context of CNS diseases,
similar activation phenotypes have been reported in per-
ipheral blood DCs from AD patients [75]. In double-
transgenic amyloid precursor protein (APP)/presenilin 1
(PS1) murine models of AD, the role of DCs in amyloid
plaque accumulation in the brain parenchyma is sup-
ported by evidence of increased formation of amyloid pla-
ques following the systemic depletion of DCs [76].
Furthermore, the activated DCs engaged with T cells at
sites of entry into the brain, presumably in response to the
amyloid plaques [77, 78]. Although T cell infiltration of
the cornea was not measured in this study, our data
highlighting DC maturation (i.e., density, immunopheno-
type, and morphology) suggest a dysregulation in corneal
immunity associated with the CNS degenerative disorders.
Recent evidence implicates that random insertions of
the MAPT P301L and associated transgenes disrupt en-
dogenous mouse genes and contribute to the neuro-
pathological phenotypes in the rTg4510 mouse model
[39]. Thus, it is relevant to examine the corneal nerves
and DC phenotype in tau transgenic mice where trans-
gene insertion has not disrupted endogenous genes
(such as the PS19 tau transgenic mouse [39]), and also
in APP/PS1 models to determine whether these neu-
roimmune changes also occur in related mouse models
of dementia.
We also found subtle changes to the subpopulations of
splenic immune cells (CD11b+ and CD11c+) in the pres-
ence of CNS tauopathy. Growing evidence supports a
role for systemic inflammation as an exacerbating force
in the pathogenesis of CNS degeneration (reviewed in
[79, 80]), with misfolded proteins [81, 82], altered per-
ipheral immune cells [83–85], and peripheral metabolic
dysregulation [86] all reported. Here, the minor changes
in the splenic CD86+ and CD80+CD11c+ populations and
the elevation of CD86+ and CD80+CD11b+ populations
in the rTg4510 mice suggest that the CD11b+ myeloid
lineage cells may be altered in rTg4510 mice. This
phenomenon is supported in part by the evidence from
peripheral blood myeloid DCs in AD where the mono-
cytic DCs have an increased expression of proinflamma-
tory markers [75]. It is hypothesized that peripheral
myeloid cells migrate to the CNS where they phagocyt-
ose tau aggregates or tau-laden neurons [87]; however,
the contribution of peripheral myeloid cells to the
pathogenesis of AD is still under debate.
Conclusion
Our data show that not only were corneal nerves altered,
but that epithelial DCs were phenotypically activated
and exhibited morphological changes in the corneas
from rTg4510 mice, suggesting a peripheral manifest-
ation of the CNS tauopathy. The changes to epithelial
DCs, followed by a loss of corneal nerve fibers, provide
new insights into the effect of CNS tauopathy on the
peripheral nervous system. These findings provide ra-
tionale for evaluating the diagnostic accuracy, including
sensitivity and specificity, of corneal imaging of epithelial
DC parameters as a disease marker in clinical popula-
tions with tauopathy.
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Additional file 1 Supplementary Fig 1S. CaMKIIa gene expression in
WT and rTg4510 mouse cornea at 3 months of age. Corneas were
assessed for gene expression of CaMKIIa, which drives the tau transgene
in rTg4510 mouse model. There was no detectable change in CaMKIIa
gene expression between WT and rTg4510 cohorts (P > 0.05). Data are
shown as mean ± SEM, where NS indicates no significant P > 0.05 (n =
11 for each genotype) as shown in the unpaired Student t-test.
Additional file 2 Supplementary Fig 2S. Gating strategies for CD80/
CD86-APC and CD45-PE. a Histogram plot showing unstained, isotype
control and positively stained population for CD80/CD86-APC antibody. b
Negative populations from unstained and isotype control and positive
population for CD45-PE antibody.
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